COMPASS Pathways PLC (CMPS)

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights

FDA granted Compass NDA rolling submission and review request, based on strength of Phase 3 data CNPV awarded for COMP360 in TRD, further...

Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Compass management will host a conference call at 8:00 am ET (1:00 pm UK)  Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated...

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...